EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,817 | +20.2% | 83,164 | +5.1% | 0.01% | +20.0% |
| Q2 2023 | $1,512 | -21.6% | 79,132 | -20.4% | 0.01% | -23.1% |
| Q1 2023 | $1,929 | +24.3% | 99,367 | +2.7% | 0.01% | +18.2% |
| Q4 2022 | $1,552 | -99.9% | 96,736 | -7.8% | 0.01% | -8.3% |
| Q3 2022 | $1,646,000 | +56.3% | 104,951 | +107.4% | 0.01% | +71.4% |
| Q2 2022 | $1,053,000 | -28.9% | 50,596 | -22.5% | 0.01% | -12.5% |
| Q1 2022 | $1,480,000 | +33.6% | 65,273 | +7.7% | 0.01% | +60.0% |
| Q4 2021 | $1,108,000 | +5.7% | 60,629 | +22.2% | 0.01% | -16.7% |
| Q3 2021 | $1,048,000 | +41.8% | 49,597 | +22.3% | 0.01% | +50.0% |
| Q2 2021 | $739,000 | -5.1% | 40,556 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $779,000 | +37.6% | 34,479 | +22.3% | 0.00% | +33.3% |
| Q4 2020 | $566,000 | +31.3% | 28,188 | +60.0% | 0.00% | 0.0% |
| Q3 2020 | $431,000 | +81.1% | 17,616 | +75.6% | 0.00% | +50.0% |
| Q2 2020 | $238,000 | -61.6% | 10,032 | -71.3% | 0.00% | -50.0% |
| Q3 2018 | $619,000 | -52.1% | 34,941 | -41.9% | 0.00% | -50.0% |
| Q2 2018 | $1,293,000 | -11.0% | 60,096 | -8.4% | 0.01% | -20.0% |
| Q1 2018 | $1,453,000 | -52.0% | 65,591 | -34.1% | 0.01% | -50.0% |
| Q4 2017 | $3,025,000 | +416.2% | 99,520 | +311.4% | 0.02% | +400.0% |
| Q3 2017 | $586,000 | +2.3% | 24,189 | +4.0% | 0.00% | 0.0% |
| Q2 2017 | $573,000 | +21.7% | 23,251 | +7.0% | 0.00% | +33.3% |
| Q1 2017 | $471,000 | +71.3% | 21,734 | +17.8% | 0.00% | +50.0% |
| Q4 2016 | $275,000 | -12.1% | 18,447 | -24.7% | 0.00% | 0.0% |
| Q3 2016 | $313,000 | +27.2% | 24,492 | -22.1% | 0.00% | 0.0% |
| Q2 2016 | $246,000 | +119.6% | 31,452 | +12.3% | 0.00% | +100.0% |
| Q1 2016 | $112,000 | -3.4% | 28,004 | +36.4% | 0.00% | 0.0% |
| Q4 2015 | $116,000 | -23.7% | 20,534 | -24.2% | 0.00% | 0.0% |
| Q3 2015 | $152,000 | +424.1% | 27,100 | +255.5% | 0.00% | – |
| Q2 2015 | $29,000 | +93.3% | 7,624 | +28.9% | 0.00% | – |
| Q1 2015 | $15,000 | +66.7% | 5,916 | +0.1% | 0.00% | – |
| Q4 2014 | $9,000 | -18.2% | 5,910 | -16.2% | 0.00% | – |
| Q3 2014 | $11,000 | -54.2% | 7,056 | 0.0% | 0.00% | – |
| Q2 2014 | $24,000 | -7.7% | 7,056 | -4.3% | 0.00% | – |
| Q1 2014 | $26,000 | -38.1% | 7,371 | +7.4% | 0.00% | – |
| Q4 2013 | $42,000 | -68.7% | 6,860 | -70.1% | 0.00% | -100.0% |
| Q3 2013 | $134,000 | +135.1% | 22,977 | +83.7% | 0.00% | 0.0% |
| Q2 2013 | $57,000 | – | 12,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |